0.000USD0.000盘前交易 08/03, 09:30 (美东)
关键数据
17.900今开
18.270最高
369.67K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.84%换手率
17.990昨收
17.495最低
5.09M成交额
亏损市盈率静
4.39市净率
0.00%股息率 TTM
-7.10%ROA
21.89052周最高
0.67量比
-30.91M净利润
44.20M总股本
-0.3841每股收益TTM
0.70Beta
-9.65%ROE
11.48052周最低
4.31%振幅
79.76%毛利率
787.64M总市值
0.66回报/风险
2.67%风险率
操作建议
SI-BONE Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名36/199位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价24.30。中期看,股价处于上升通道。近一个月,市场表现一般,但基本面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。
压力支撑

由于公司未披露,未能获取相关数据
SI-BONE Inc新闻
即将为您带来更多新闻,敬请期待。。。
收益预测
Zimmer Biomet Holdings Inc
ZBH
31
技术指标
财务指标
每股收益

由于公司未披露,未能获取相关数据
营业总收入

由于公司未披露,未能获取相关数据
SI-BONE Inc简介
SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
公司代码SIBN
公司SI-BONE Inc
CEOFrancis (Laura A)
网址https://si-bone.com/
公司股东
常见问题
SI-BONE Inc(SIBN)的当前股价是多少?
SI-BONE Inc(SIBN)的当前股价是 17.76。
SI-BONE Inc股票的52周最高点是多少?
SI-BONE Inc股票的52周最高点是21.89。
SI-BONE Inc股票的52周最低点是多少?
SI-BONE Inc股票的52周最低点是11.48。
现在SI-BONE Inc(SIBN)的股票是买入、持有还是卖出?
根据分析师评级,SI-BONE Inc(SIBN)的总体评级为买入,目标价格为24.30。
SI-BONE Inc(SIBN)股票的每股收益(EPS TTM)是多少
SI-BONE Inc(SIBN)股票的每股收益(EPS TTM)是-0.44。